Nova Leap Health Corp (NLH) — Capital Reinvestment Ratio

Latest as of March 2023: 0.10x

Nova Leap Health Corp (NLH) has a Capital Reinvestment Ratio of 0.10x as of March 2023, meaning it reinvests 0% of its operating cash flow (CA$294.33K) in capital expenditures (CA$27.99K). Check NLH goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.10x
Capex / Operating Cash Flow

Operating Cash Flow

CA$294.33K
CAD

Capital Expenditures

CA$27.99K
CAD

Data as of

Mar 2023
Most recent filing

Nova Leap Health Corp Capital Reinvestment Ratio (2019–2024)

This chart tracks Nova Leap Health Corp's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see how efficiently does Nova Leap Health Corp generate cash.

Annual Capital Reinvestment Ratio for Nova Leap Health Corp (2019–2024)

Year-by-year Capital Reinvestment Ratio for Nova Leap Health Corp from 2019 to 2024. See cash generation quality of Nova Leap Health Corp to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CAD) Capital Expenditures YoY Change
2024 0.02x CA$1.39 Million CA$25.00K ▲ +38.6%
2023 0.01x CA$2.15 Million CA$27.99K ▼ -81.4%
2022 0.07x CA$1.02 Million CA$71.24K ▲ +113.6%
2021 0.03x CA$2.18 Million CA$71.24K ▲ +1365.2%
2020 0.00x CA$3.01 Million CA$6.72K ▼ -91.2%
2019 0.03x CA$613.80K CA$15.48K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow